ArticleCommunications biology2026
Tiki2 restrains Wnt5a/Ror signaling to limit inflammation in acute kidney injury.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Ischemia/reperfusion (IR)-induced acute kidney injury (AKI) occurs in a range of clinical settings and is characterized by pronounced inflammation, but the underlying regulatory mechanisms remain incompletely understood. Tiki2 is a Wnt inhibitor that is highly expressed in the kidney and its function has not been defined. Here, we show that Tiki2 is enriched in proximal tubular epithelial cells (PTECs) and is dynamically regulated during IR-induced AKI. Tubule-specific ablation of Tiki2 exacerbates immune cell infiltration and tubular injury following IR. Mechanistically, loss of Tiki2 leads to increased activation of Wnt5a/Ror signaling, which is induced in PTECs after IR injury, resulting in increased JNK and ERK activation and elevated expression of chemokines and cytokines that promote the infiltration of immune cells. Notably, the aggravated injury and inflammation caused by Tiki2 deficiency are reversed by Ror2 knockdown in PTECs. Together, these findings identify Tiki2 as a negative regulator of Wnt5a/Ror signaling in renal tubular cells and highlight the Tiki2-Wnt5a/Ror axis as a potential therapeutic target in IR-induced AKI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.